HSBC Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-8,991
| Closed | -$330K | – | 2557 |
|
2024
Q4 | $330K | Buy |
8,991
+1,707
| +23% | +$62.6K | ﹤0.01% | 2036 |
|
2024
Q3 | $355K | Buy |
7,284
+566
| +8% | +$27.5K | ﹤0.01% | 1859 |
|
2024
Q2 | $271K | Sell |
6,718
-711
| -10% | -$28.7K | ﹤0.01% | 2006 |
|
2024
Q1 | $326K | Buy |
+7,429
| New | +$326K | ﹤0.01% | 1996 |
|
2023
Q4 | – | Sell |
-7,163
| Closed | -$330K | – | 2223 |
|
2023
Q3 | $330K | Buy |
+7,163
| New | +$330K | ﹤0.01% | 1701 |
|
2023
Q1 | – | Sell |
-10,370
| Closed | -$289K | – | 2212 |
|
2022
Q4 | $289K | Buy |
10,370
+2,277
| +28% | +$63.4K | ﹤0.01% | 2112 |
|
2022
Q3 | $232K | Buy |
8,093
+505
| +7% | +$14.5K | ﹤0.01% | 2120 |
|
2022
Q2 | $263K | Sell |
7,588
-828
| -10% | -$28.7K | ﹤0.01% | 2295 |
|
2022
Q1 | $308K | Buy |
+8,416
| New | +$308K | ﹤0.01% | 2374 |
|
2021
Q4 | – | Sell |
-21,718
| Closed | -$420K | – | 2742 |
|
2021
Q3 | $420K | Hold |
21,718
| – | – | ﹤0.01% | 1915 |
|
2021
Q2 | $435K | Sell |
21,718
-1,215
| -5% | -$24.3K | ﹤0.01% | 1871 |
|
2021
Q1 | $420K | Sell |
22,933
-1,380
| -6% | -$25.3K | ﹤0.01% | 1755 |
|
2020
Q4 | $485K | Hold |
24,313
| – | – | ﹤0.01% | 1820 |
|
2020
Q3 | $460K | Buy |
24,313
+716
| +3% | +$13.5K | ﹤0.01% | 1602 |
|
2020
Q2 | $530K | Buy |
23,597
+6,265
| +36% | +$141K | ﹤0.01% | 1460 |
|
2020
Q1 | $255K | Buy |
17,332
+4,902
| +39% | +$72.1K | ﹤0.01% | 1743 |
|
2019
Q4 | $240K | Sell |
12,430
-16,093
| -56% | -$311K | ﹤0.01% | 2171 |
|
2019
Q3 | $566K | Buy |
+28,523
| New | +$566K | ﹤0.01% | 1697 |
|